Clovoxamine

Chemical compound
  • none
Legal statusLegal status
  • In general: uncontrolled
Identifiers
  • 1-(4-chlorophenyl)-5-methoxypentan-1-one O-2-aminoethyl oxime
CAS Number
  • 54739-19-4 checkY
  • fumarate: 54739-21-8 checkY
PubChem CID
  • 6335903
ChemSpider
  • 4891461 ☒N
UNII
  • 7I22J7RY2A
  • fumarate: 21VG81S0IX checkY
ChEMBL
  • ChEMBL2105603 ☒N
Chemical and physical dataFormulaC14H21ClN2O2Molar mass284.78 g·mol−13D model (JSmol)
  • Interactive image
  • COCCCCC(=NOCCN)C1=CC=C(C=C1)Cl
InChI
  • InChI=1S/C14H21ClN2O2/c1-18-10-3-2-4-14(17-19-11-9-16)12-5-7-13(15)8-6-12/h5-8H,2-4,9-11,16H2,1H3/b17-14+ ☒N
  • Key:XXPVSQRPGBUFKM-SAPNQHFASA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Clovoxamine (INN) (developmental code name DU-23811) is a drug that was discovered in the 1970s and was subsequently investigated as an antidepressant and anxiolytic agent but was never marketed.[1][2][3] It acts as a serotonin-norepinephrine reuptake inhibitor (SNRI), with little affinity for the muscarinic acetylcholine, histamine, adrenergic, and serotonin receptors.[4][5] The compound is structurally related to fluvoxamine.

References

  1. ^ Freeman HL, Wakelin JS, Calanca A, Hole G (1982). "Initial clinical evaluation of a new nontricyclic antidepressant: clovoxamine". Advances in Biochemical Psychopharmacology. 32: 69–75. PMID 7046368.
  2. ^ Jesinger DK, Gostick N (October 1989). "Anxiety neurosis in general practice. A double-blind comparative study of diazepam and clovoxamine, a novel inhibitor of noradrenaline and serotonin reuptake". International Clinical Psychopharmacology. 4 (4): 301–11. doi:10.1097/00004850-198910000-00005. PMID 2691573.
  3. ^ Hurst HE, Jones DR, Wright JH, Jarboe CH (August 1983). "Clovoxamine kinetics in an early clinical trial". Clinical Pharmacology and Therapeutics. 34 (2): 266–71. doi:10.1038/clpt.1983.164. PMID 6872422. S2CID 42205772.
  4. ^ Saletu B, Grünberger J, Rajna P, Karobath M (1980). "Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man". Journal of Neural Transmission. 49 (1–2): 63–86. doi:10.1007/BF01249190. PMID 6777458. S2CID 6483654.
  5. ^ Bradford LD, Tulp MT, Schipper J (June 1987). "Biochemical effects in rats after acute and long-term treatment with clovoxamine". Archives Internationales de Pharmacodynamie et de Therapie. 287 (2): 188–202. PMID 2820327.
  • v
  • t
  • e
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
  • See also: Receptor/signaling modulators
  • Dopaminergics
  • Serotonergics
  • Monoamine reuptake inhibitors
  • Monoamine releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins
  • v
  • t
  • e
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
  • See also: Receptor/signaling modulators
  • Adrenergics
  • Dopaminergics
  • Melatonergics
  • Monoamine reuptake inhibitors and releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins
Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e